Tecogen Inc. (TGEN) Stock Price & Analysis
Tecogen Inc. (TGEN) fell 6.90% to USD 5.67 as of June 10, 2026 at 03:39 UTC, according to Nexqual real-time market data.
TGEN last closed at USD 6.09; the session ranged USD 5.3–6.34 on volume of 606,657 shares. Market capitalization is $169.63M, with a 52-week range of USD 1.94–12.07 (ASE). Source: Nexqual, June 10, 2026 at 03:39 UTC.
Key Statistics (as of June 10, 2026 at 03:39 UTC)
| Price | USD 5.67 |
|---|---|
| Change | ▼ 6.90% (down) |
| Previous Close | USD 6.09 |
| Open | USD 6.19 |
| Day Range | USD 5.3 – 6.34 |
| 52-Week Range | USD 1.94 – 12.07 |
| Volume | 606,657 shares |
| Market Cap | $169.63M |
| Exchange | ASE |
Technical Analysis (TGEN)
Nexqual's technical model rates TGEN "NEUTRAL" based on 3 bullish and 2 bearish signals across 124 daily candles, as of June 10, 2026 at 03:39 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 49.59 (neutral) |
| vs SMA50 | Above (USD 4.75) |
| MACD | 0.4 (positive) |
Analyst Ratings (TGEN)
Wall Street analysts rate TGEN "None" based on 3 analysts, with a mean price target of USD 8.83 (range USD 7.5–10), per Nexqual as of June 10, 2026 at 03:39 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 3 |
| Mean Target | USD 8.83 |
| High Target | USD 10 |
| Low Target | USD 7.5 |
| Buy / Hold / Sell | 3 / 0 / 0 |
Earnings (TGEN)
| Next Earnings Date | 2026-08-12 |
|---|---|
| EPS Estimate | USD -0.08 |
| Revenue Estimate | $5.85M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2025-12-31 | USD -0.1 vs est -0.1 ▲ beat |
| 2025-09-30 | USD -0.07 vs est -0.05 ▼ miss |
Source: Nexqual, June 10, 2026 at 03:39 UTC.
Financials & Fundamentals (TGEN)
| Total Revenue | $26.13M |
|---|---|
| Revenue Growth (YoY) | -12.90% |
| Gross Margin | +35.18% |
| Operating Margin | -33.67% |
| Profit Margin | -37.16% |
| ROE | -66.83% |
| Debt / Equity | 14.61 |
| Current Ratio | 3.02 |
| Total Cash | $9.33M |
| Total Debt | $2.86M |
| Free Cash Flow | $-11.05M |
Source: Nexqual, June 10, 2026 at 03:39 UTC.
Financial Health Score (TGEN)
Nexqual rates Tecogen Inc.'s overall financial health "Weak" across five dimensions, as of June 10, 2026 at 03:39 UTC.
| Growth | Critical — Revenue -13% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Strong — $9M cash vs $3M debt, net cash position |
| Cash Flow | Weak — FCF negative: -$11M, burning cash |
| Efficiency | Critical — ROE -67%, ROA -16.9% |
Ownership (TGEN)
| Insider Ownership | +39.10% |
|---|---|
| Institutional Ownership | +29.45% |
| Shares Outstanding | 29.92M |
| Float | 18.14M |
| Short % of Float | +4.53% |
Source: Nexqual, June 10, 2026 at 03:39 UTC.
Leadership (TGEN)
Tecogen Inc. is led by Abinand Rangesh (age 39), CEO & Director, per Nexqual as of June 10, 2026 at 03:39 UTC.
| CEO & Director | Abinand Rangesh (age 39) |
|---|---|
| President & COO | Robert A. Panora (age 71) |
| CFO, Treasurer & Chief Accounting Officer | Roger P. Deschenes (age 66) |
| Vice President of Business Development | Stephen Lafaille (age 37) |
Major Backers & Investors (TGEN)
Notable institutional backers of Tecogen Inc. include Fidelity, Bard Associates Inc., Clear Harbor Asset Management, LLC, according to Nexqual as of June 10, 2026 at 03:39 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Fidelity | 3.25% |
| Bard Associates Inc. | 2.75% |
| Clear Harbor Asset Management, LLC | 2.6% |
| Portolan Capital Management, LLC | 1.78% |
| Herald Investment Management Ltd | 1.68% |
| Arosa Capital Management LP | 1.4% |
| Palisades Investment Partners, LLC | 1.34% |
| UBS Group AG | 1.28% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 6.08% |
Source: Nexqual, June 10, 2026 at 03:39 UTC.
From Tecogen Inc.'s Latest SEC 10-K Filing (filed 2026-03-19)
Key Strengths & Strategy (as disclosed to the SEC)
- Tecogen Inc., together with its subsidiaries, designs, manufactures, markets, and maintains cogeneration products for multi-family residential, commercial, recreational, and industrial use in the United States.
- It operates in three segments: Products, Services, and Energy Production.
- Its Services segment provides operations and maintenance services; and parts sales, and installation services.
- The Energy Production segment installs, operates, and maintains distributed own generation electricity systems and sells the energy generated by such systems in the form of electricity, heat, hot water, and cooling to its customers under long-term energy sales agreements.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CASIF | CASI Pharmaceuticals, Inc. | USD 0.1 | ▼ 21.54% |
| NGEN | NervGen Pharma Corp. | USD 1.81 | ▼ 2.69% |
| GNTA | Genenta Science S.p.A. | USD 1.6 | ▼ 21.57% |
| XOMA | XOMA Royalty Corporation | USD 41.95 | ▼ 0.33% |
| VRA | Vera Bradley, Inc. | USD 3.3 | ▲ 7.14% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 03:39 UTC. This page is informational and not investment advice.